Characterization of a new animal model for evaluation and treatment of back pain due to lumbar facet joint osteoarthritis.

OBJECTIVE Osteoarthritic (OA) degeneration of the lumbar facet joints has been implicated in low back pain. This study was undertaken to investigate the biologic links between cellular and structural alterations within facet joint components and the development of symptomatic chronic back pain. METHODS We generated an animal model of facet joint degeneration by intraarticular injection of monosodium iodoacetate (MIA) into facet joints (L3-L4, L4-L5, L5-L6) of Sprague-Dawley rats. Pain sensation due to pressure, which mimics a mechanical stimulus for facet joint injury, was measured using an algometer. Pain response was also assessed in a straight leg raising test. Cartilage alterations were assessed by biochemical evaluation and microfocal computed tomography (micro-CT). Therapeutic modulation of chronic facet joint pain with the use of various pharmacologic agents was investigated. RESULTS MIA injection resulted in severely damaged facet joint cartilage, proteoglycan loss, and alterations of subchondral bone structure. Micro-CT analyses suggested that the behavioral hyperalgesia from facet joint degeneration was not associated with foraminal stenosis. The biologic and structural changes in facet joints were closely associated with sustained and robust chronic pain. Morphine and pregabalin markedly alleviated pressure hyperalgesia, while celecoxib (a selective inhibitor of cyclooxygenase 2 [COX-2]) produced moderate antihyperalgesic effects and the effect of ketorolac (an inhibitor of COX-1 and COX-2) was negligible. CONCLUSION Our findings demonstrate that MIA injection provides a useful model for the study of OA changes in the facet joint and indicate that facet joint degeneration is a major cause of chronic low back pain. The treatment results suggest that classes of drugs that are widely used to treat OA, such as nonsteroidal antiinflammatory drugs, may have limited efficacy once joint destruction is complete.

[1]  T. Mayadas,et al.  Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. , 1998, Journal of immunology.

[2]  A. Dolphin,et al.  Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain , 2009, Molecular pain.

[3]  R. Head,et al.  Transcriptional profiling and pathway analysis of monosodium iodoacetate-induced experimental osteoarthritis in rats: relevance to human disease. , 2007, Osteoarthritis and cartilage.

[4]  N. Bogduk,et al.  Clinical Features of Patients with Pain Stemming from the Lumbar Zygapophysial Joints: Is the Lumbar Facet Syndrome a Clinical Entity? , 1994, Spine.

[5]  T. Oegema,et al.  Facet Joint Changes After Chemonucleolysis-induced Disc Space Narrowing , 1986, Spine.

[6]  David D. McErlain,et al.  Forced mobilization accelerates pathogenesis: characterization of a preclinical surgical model of osteoarthritis , 2007, Arthritis Research & Therapy.

[7]  H. Rijswijk,et al.  Comment on stEP (Scholz J, Mannion RJ, Hord DE, Griffin RS, Rawal B et al(2009)) A Novel Tool for the Assessment of Pain: Validation in Low Back Pain , 2009 .

[8]  H. Farfan,et al.  Instability of the lumbar spine. , 1982, Clinical orthopaedics and related research.

[9]  R. Dworkin,et al.  Non-steroidal anti-inflammatory drugs for neuropathic pain: How do we explain continued widespread use? , 2009, PAIN®.

[10]  N. Bogduk,et al.  Prevalence and clinical features of lumbar zygapophysial joint pain: a study in an Australian population with chronic low back pain. , 1995, Annals of the rheumatic diseases.

[11]  Z. Wen,et al.  Intra-articular injection of collagenase induced experimental osteoarthritis of the lumbar facet joint in rats , 2008, European Spine Journal.

[12]  I. Gilron.  Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions , 2007, Current opinion in anaesthesiology.

[13]  D. R. Sumner,et al.  Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. , 2010, Arthritis and rheumatism.

[14]  J. Kroin,et al.  Characterization of Pain and Pharmacologic Responses in an Animal Model of Lumbar Adhesive Arachnoiditis , 2005, Spine.

[15]  B. Vernon‐roberts,et al.  Osteoarthrosis of the facet joints resulting from anular rim lesions in sheep lumbar discs. , 1999, Spine.

[16]  Bhupendra Rawal,et al.  A Novel Tool for the Assessment of Pain: Validation in Low Back Pain , 2009, PLoS medicine.